BioCardia Files 8-K Report
Ticker: BCDA · Form: 8-K · Filed: Jun 25, 2025 · CIK: 925741
| Field | Detail |
|---|---|
| Company | Biocardia, Inc. (BCDA) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory-compliance
Related Tickers: BCDA
TL;DR
BioCardia filed its 8-K. Standard reporting stuff.
AI Summary
On June 25, 2025, BioCardia, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific new financial figures or material events were detailed in the provided excerpt, but it indicates ongoing reporting and compliance activities for the company.
Why It Matters
This filing indicates BioCardia, Inc. is meeting its regulatory reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine SEC filing for ongoing reporting and does not disclose new material events or financial information.
Key Players & Entities
- BioCardia, Inc. (company) — Registrant
- June 25, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-38999 (identifier) — Commission File Number
- 23-2753988 (identifier) — IRS Employer Identification No.
- 320 Soquel Way Sunnyvale, California 94085 (address) — Address of principal executive offices
- (650) 226-0120 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for BioCardia, Inc.?
The filing is for "Other Events" and "Financial Statements and Exhibits," indicating ongoing regulatory reporting and compliance.
When was the earliest event reported in this filing?
The earliest event reported was on June 25, 2025.
In which state is BioCardia, Inc. incorporated?
BioCardia, Inc. is incorporated in Delaware.
What is BioCardia, Inc.'s principal executive office address?
The principal executive office is located at 320 Soquel Way, Sunnyvale, California 94085.
Does this filing disclose any new material financial information or specific events?
Based on the provided excerpt, this filing primarily concerns routine reporting and does not detail new material financial information or specific events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding BioCardia, Inc. (BCDA).